Nima Farzan

Nima Farzan

Chief Executive Officer at LATIGO BIOTHERAPEUTICS, INC.

Net worth: 2 M $ as of 2026-07-30

50 year
Health Technology
Consumer Services
Commercial Services

Profile

Nima M.
Farzan
is President, Chief Executive Officer & Director at Latigo Biotherapeutics, Inc. since 2024.
Mr. Farzan is an Independent Director at Keros Therapeutics, Inc. since 2020.
Mr. Farzan is a Director at the Coalition for Epidemic Preparedness Innovations.
Mr. Farzan is a Trustee at The Hamlin School.
Former roles include President, Chief Executive Officer & Director at Kinnate Biopharma, Inc. from 2020 to 2024.
President, Chief Executive Officer & Director at Emergent Travel Health, Inc. from 2015 to 2018.
President & Chief Executive Officer at Paxvax Corp.
from 2015 to 2018.
Director-Strategic Marketing at DoubleTwist, Inc. from 1997 to 1999.
Director-Disease Area Strategy at Novartis AG from 2003 to 2011.
Vice President-Marketing at Novartis Vaccines & Diagnostics, Inc. Venture Partner at Foresite Capital Management LLC in 2024.
Associate at The Boston Consulting Group, Inc. from 1997 to 1999.
Education includes undergraduate degree from Stanford University and MBA from Harvard Business School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-08-06 114,453 ( 0.18% ) 2 M $ 2026-07-30
2026-06-03 9,767 ( 0.05% ) 98 354 $ 2026-07-30

Nima Farzan active positions

CompaniesPositionStart
KEROS THERAPEUTICS, INC. Director/Board Member 2020-02-29
LATIGO BIOTHERAPEUTICS, INC. Chief Executive Officer 2024-07-21
Corporate Officer/Principal -
Coalition for Epidemic Preparedness Innovations
Director/Board Member -

Former positions of Nima Farzan

CompaniesPositionEnd
Corporate Officer/Principal 2024-06-30
KINNATE BIOPHARMA INC. Chief Executive Officer 2024-04-02
Chief Executive Officer 2018-09-30
Paxvax Corp.
Chief Executive Officer 2018-09-30
NOVARTIS AG Corporate Officer/Principal 2010-12-31
See the detail of Nima Farzan's experience

Training of Nima Farzan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

74

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Commercial Services

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

Consumer Services

Finance

Consumer Services

Health Technology

Coalition for Epidemic Preparedness Innovations

Health Technology

Health Technology

Paxvax Corp.